Sonoma Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SNOA Sonoma Pharmaceuticals Inc
CUBE CubeSmart
MRAM Everspin Technologies Inc
LULU Lululemon Athletica Inc
SSYS Stratasys Ltd
ASTE Astec Industries Inc
NHTC Natural Health Trends Corp
DB Deutsche Bank AG
XPER Xperi Holding Corp
TT Trane Technologies PLC
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets solutions for management of dermatological conditions and advanced tissue care. The Company's product portfolio consists of dermatology, animal health, and advanced tissue care products based upon its Microcyn technology. Its Microcyn technology family of products consists of liquids and gels, which contain small molecule oxychlorine compounds. Its products serve patients across the globe by reducing infections, itch, pain, scarring and inflammatory responses. Its products are sold throughout the United States and internationally.

Closing Price
$7.78
Day's Change
-0.08 (-1.02%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.90
Day's Low
7.65
Volume
(Light)
Volume:
23,306

10-day average volume:
124,021
23,306

There is no peer information for SNOA.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.